Base de dados : HANSEN
Pesquisa : RIFAMPINA/SANGUE [Descritor de assunto]
Referências encontradas : 2 [refinar]
Mostrando: 1 .. 2   no formato [Detalhado]

página 1 de 1

  1 / 2 HANSEN  
              next record last record
seleciona
para imprimir
Id:18179
Autor:Shepard, Charles C; Walker, Laura L; Van Landingham, Rosalind M; Redus, Martha A
Título:Kinetic testing of drugs against Mycobacterium leprae in mice. Activity of cephaloridine, rifampin, streptovaricin, vadrine, and viomycin
..-
Fonte:s.l; s.n; jul. 1971. 5 p. tab, graf.
Resumo:A series of drugs that had been found active against Mycobacterium leprae in mice by the continous method of drug administration was tested by the kinetic method. Vadrine and vyomivin were found inactive. Cephaloridine, streptovaricin, and rifampin gave bactericidal-type results. In a second experiment, rifampin was found to have distinct bactericidal effect when given for only 2 days. The plasma levels of rifampin that were associated with bactericidal effect in mice were in the range reported for man receiving acceptable dosages of rifampin. Cephaloridine and, especially, rifampin merit further investigation in clinical trials in leprosy patients, either as single drugs or in combination with other active drugs. The combination of rifampin and dapsone (DDS) or acedapsone (DADDS) appear to provide the advantages of tboth drugs.(AU).
Descritores:ANTIMALARICOS/admin
DAPSONA/admin
INJECOES SUBCUTÂNEAS
HANSENIASE/quimioter
MYCOBACTERIUM LEPRAE/ef drogas
MYCOBACTERIUM LEPRAE/cresc
RIFAMPINA/admin
RIFAMPINA/sangue
VIOMICINA/admin
DIETA
 ESTUDOS DE AVALIACAO
 CINETICA
 MALARIA/sangue
 OXIDIAZOIS/admin
 PIRIDINAS/admin
 ACIDOS SALICILICOS/admin
 ESTREPTOVARICINA/admin
Limites:ANIMAL
CAMUNDONGOS
Meio Eletrônico: - .
Localização:BR191.1; 02305/s


  2 / 2 HANSEN  
              first record previous record
seleciona
para imprimir
Id:17866
Autor:Aronne Benach, M. T; Naranjo Cascante, G
Título:Estudio de biodisponibilidad en dos preparaciones distintas de rifampicina
Bioavailability of 2 different rifampicin preparations-
Fonte:s.l; s.n; October 15, 1980. 4 p. tab, graf.
Resumo:Blood levels of two different preparations of Rifampicin were determined after a standard dose of 600mg. Three hours later, blood concentrations showed no statistical differences. Six hours later the levels were statiscally significant well above the minimum inhibitory levels for Mycobacterium Tuberculosis. For practical purposes it may be said that no diference in th bioavailability existis between the two drugs studied...(AU).
Descritores:ABSORCAO INTESTINAL
FATORES DE TEMPO
DISPONIBILIDADE BIOLOGICA
ENSAIOS CLINICOS
AVALIACAO DE MEDICAMENTOS
RIFAMPINA/sangue
RIFAMPINA/metab
RIFAMPINA/urina
Limites:HUMANO
MASCULINO
FEMININO
ADULTO
MEIA-IDADE
ADOLESCENTE
RESUMO EM INGLES
Meio Eletrônico: - .
Localização:BR191.1; 00679/s



página 1 de 1
   


Refinar a pesquisa
  Base de dados : HANSEN Formulário avançado   
Pesquisar por : Formulário livre   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6.1 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information